155 related articles for article (PubMed ID: 17372686)
1. Raman chemical imaging for ingredient-specific particle size characterization of aqueous suspension nasal spray formulations: a progress report.
Doub WH; Adams WP; Spencer JA; Buhse LF; Nelson MP; Treado PJ
Pharm Res; 2007 May; 24(5):934-45. PubMed ID: 17372686
[TBL] [Abstract][Full Text] [Related]
2. Analytical method development for characterizing ingredient-specific particle size distributions of nasal spray suspension products.
Thomas BJ; Absar M; Delvadia R; Conti DS; Witzmann K; Guo C
J Pharm Sci; 2021 Jul; 110(7):2778-2788. PubMed ID: 33713688
[TBL] [Abstract][Full Text] [Related]
3. Assessment of active pharmaceutical ingredient particle size in tablets by Raman chemical imaging validated using polystyrene microsphere size standards.
Kuriyama A; Ozaki Y
AAPS PharmSciTech; 2014 Apr; 15(2):375-87. PubMed ID: 24414886
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products.
Farias G; Shur J; Price R; Bielski E; Newman B
AAPS J; 2021 May; 23(4):73. PubMed ID: 34008082
[TBL] [Abstract][Full Text] [Related]
5. Analyzing ophthalmic suspension particle size distributions using laser diffraction: Placebo background subtraction method.
Vo A; Feng X; Smith WC; Zhu D; Patel M; Kozak D; Wang Y; Zheng J; Ashraf M; Xu X
Int J Pharm; 2021 Apr; 598():120401. PubMed ID: 33636327
[TBL] [Abstract][Full Text] [Related]
6. Limitations of high dose carrier based formulations.
Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
Int J Pharm; 2018 Jun; 544(1):141-152. PubMed ID: 29649519
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a direct, non-destructive quantitative method for medroxyprogesterone acetate in a pharmaceutical suspension using FT-Raman spectroscopy.
De Beer TR; Vergote GJ; Baeyens WR; Remon JP; Vervaet C; Verpoort F
Eur J Pharm Sci; 2004 Dec; 23(4-5):355-62. PubMed ID: 15567288
[TBL] [Abstract][Full Text] [Related]
8. Non-impactor-based methods for sizing of aerosols emitted from orally inhaled and nasal drug products (OINDPs).
Mitchell J; Bauer R; Lyapustina S; Tougas T; Glaab V
AAPS PharmSciTech; 2011 Sep; 12(3):965-88. PubMed ID: 21785912
[TBL] [Abstract][Full Text] [Related]
9. Particle Size Measurements from Orally Inhaled and Nasal Drug Products.
Mitchell JP
J Aerosol Med Pulm Drug Deliv; 2021 Dec; 34(6):325-345. PubMed ID: 34860563
[TBL] [Abstract][Full Text] [Related]
10. Topologically directed confocal Raman imaging (TD-CRI): Advanced Raman imaging towards compositional and micromeritic profiling of a commercial tablet components.
Muthudoss P; Kumar S; Ann EYC; Young KJ; Chi RLR; Allada R; Jayagopal B; Dubala A; Babla IB; Das S; Mhetre S; Saraf I; Paudel A
J Pharm Biomed Anal; 2022 Feb; 210():114581. PubMed ID: 35026592
[TBL] [Abstract][Full Text] [Related]
11. Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation.
Pozzoli M; Rogueda P; Zhu B; Smith T; Young PM; Traini D; Sonvico F
Drug Dev Ind Pharm; 2016 Oct; 42(10):1660-8. PubMed ID: 26953090
[TBL] [Abstract][Full Text] [Related]
12. Raman characterization and chemical imaging of biocolloidal self-assemblies, drug delivery systems, and pulmonary inhalation aerosols: a review.
Mansour HM; Hickey AJ
AAPS PharmSciTech; 2007 Nov; 8(4):E99. PubMed ID: 18181559
[TBL] [Abstract][Full Text] [Related]
13. Red-excitation dispersive Raman spectroscopy is a suitable technique for solid-state analysis of respirable pharmaceutical powders.
Vehring R
Appl Spectrosc; 2005 Mar; 59(3):286-92. PubMed ID: 15901308
[TBL] [Abstract][Full Text] [Related]
14. Influence of the size of micronized active pharmaceutical ingredient on the aerodynamic particle size and stability of a metered dose inhaler.
Berry J; Kline LC; Sherwood JK; Chaudhry S; Obenauer-Kutner L; Hart JL; Sequeira J
Drug Dev Ind Pharm; 2004 Aug; 30(7):705-14. PubMed ID: 15491048
[TBL] [Abstract][Full Text] [Related]
15. Drug characterization in low dosage pharmaceutical tablets using Raman microscopic mapping.
Henson MJ; Zhang L
Appl Spectrosc; 2006 Nov; 60(11):1247-55. PubMed ID: 17132441
[TBL] [Abstract][Full Text] [Related]
16. Scientific Considerations for the Review and Approval of First Generic Mometasone Furoate Nasal Suspension Spray in the United States from the Bioequivalence Perspective.
Liu Q; Absar M; Saluja B; Guo C; Chowdhury B; Lionberger R; Conner DP; Li BV
AAPS J; 2019 Jan; 21(2):14. PubMed ID: 30617594
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of transmission Raman spectroscopy for rapid quantitative analysis of intact multi-component pharmaceutical capsules.
Hargreaves MD; Macleod NA; Smith MR; Andrews D; Hammond SV; Matousek P
J Pharm Biomed Anal; 2011 Feb; 54(3):463-8. PubMed ID: 20947277
[TBL] [Abstract][Full Text] [Related]
18. Dispersibility of lactose fines as compared to API in dry powders for inhalation.
Thalberg K; Åslund S; Skogevall M; Andersson P
Int J Pharm; 2016 May; 504(1-2):27-38. PubMed ID: 26965200
[TBL] [Abstract][Full Text] [Related]
19. Comparison of optical particle sizing and cascade impaction for measuring the particle size of a suspension metered dose inhaler.
Pu Y; Kline LC; Khawaja N; Van Liew M; Berry J
Drug Dev Ind Pharm; 2015 May; 41(5):737-43. PubMed ID: 24641447
[TBL] [Abstract][Full Text] [Related]
20. The influence of spray-drying parameters on phase behavior, drug distribution, and in vitro release of injectable microspheres for sustained release.
Meeus J; Lenaerts M; Scurr DJ; Amssoms K; Davies MC; Roberts CJ; Van Den Mooter G
J Pharm Sci; 2015 Apr; 104(4):1451-60. PubMed ID: 25648704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
